L'Oréal: Elite Execution, a Flat Stock, and a Multiple That's Fully Paid

L'Oréal just reported one of its strongest first halves in years — record operating margins, sales growth ahead of the entire beauty market — and its shares went essentially nowhere. Over the past year the stock drifted down a few percent even as the business set new marks. That gap between a company that is clearly winning and a price that refuses to move is the whole question for anyone weighing a buy.

The natural read is that the market is leaving money on the table. The worth-asking question is whether that's true — and to answer it you have to separate a company that is genuinely excellent from a share price that has already paid for the excellence.

Record margins, a flat stock

Start with the operating proof, because that part is unambiguous. In the first half of 2026, L'Oréal's sales reached €23.77 billion, up 6.5% on the adjusted like-for-like measure it uses as its headline — 6.8% like-for-like and 5.8% reported, where the reported figure counts currency swings and acquisitions while like-for-like excludes them. (Like-for-like strips out exchange-rate movement and the effect of newly opened stores, so it is the cleanest read on true underlying demand.) The company estimates the global beauty market grew only about 4.5% in the first quarter and roughly 5% in the second, meaning L'Oréal outpaced the market by around 200 basis points. That "market" figure is L'Oréal's own estimate, not an independent count. The pace is also steady, not spiky: the first quarter ran at 6.7%.

The margin is where it gets genuinely impressive. Operating profit rose 6.8% to €5.06 billion, lifting the adjusted operating margin to a record 21.3%, up 20 basis points from a year ago. In plain terms, about 21 cents of every euro of sales now drops through as operating profit, and the company managed that while spending roughly €700 million more on advertising than a year earlier. Gross margin sits in the mid-70s, at 74.8%. That is the profile of a business with real pricing power: it is growing, and it is getting more profitable as it grows, not less.

You're not paying a discount

Here is the part a headline can hide. A flat stock after a record half can look like a free lunch — a great company at a cheap price. But look at what you are actually paying. At about €388 a share and a market value near €205 billion, L'Oréal trades at roughly 33 times its earnings and, on a free-cash-flow basis, about 27 times. A multiple that high is only "worth it" if the company keeps compounding at mid-to-high single digits for years. And the 1.4% dividend gives you almost no cushion if growth stalls; the company has paid out for 35 consecutive years, but a yield like that is support, not a return.

So the flat price is best read not as undervaluation but as underwriting. The market is not punishing L'Oréal; it has simply decided the multiple is full. Every extra point of growth has to earn its keep before the price moves up. That reframes the question from "is the stock cheap?" to "does the next operating phase justify paying 33 times?" That is a higher bar, and the business has to clear it in the reported numbers, not in the story.

The whole thesis runs through China

This is where the good story and the risky story meet. L'Oréal's growth is broad — emerging markets ran near 10%, Europe accelerated to 7-8%, Vietnam jumped 50% and India 17%, and the United States (about a quarter of the business) grew in the mid-single digits. One category is a bright spot inside the broad picture: haircare grew 15.6%. But a single region carries outsized weight: China is roughly 17% of total sales.

In China, L'Oréal's luxury brands grew about 10%, and its short-video commerce on Douyin grew 55% during the June shopping period — part of a broader e-commerce channel that now accounts for about 65% of its China business. Management itself flags the catch: Douyin "requires a different profitability model." That is a useful warning in a single sentence, and it matters because China is where the premium, margin-rich part of L'Oréal's business is concentrated — luxury is about 60% of its China sales. If China slows, it hits revenue and margin at the same time.

Meanwhile, one category is visibly lagging. Makeup grew just 2.5%, well behind the rest, because it is cyclical and tied to fast-shifting fashion. It is small in the overall picture, but it is the one place where "everything is growing" is simply not true.

And the things getting the most press — partnerships with OpenAI, NVIDIA, IBM and Meta to speed up formula development, plus new categories such as beauty supplements and products aimed at GLP-1 users — are not in these numbers yet. They are plausible, but they are narrative, not demonstrated demand. A 33-times price should not include a premium for a promise.

What the 33-times multiple is asking you to believe

The business is elite and it is executing. That is proven, and it is worth being clear: the risk here is not that L'Oréal is a bad company. The risk is that you are already paying the price for a good company to keep being good.

This is a "pay up" decision, not a "buy the dip" one — no reset has happened, and 33 times is not a discount. The honest read is to wait rather than chase. The entry gets more attractive if the multiple dips on a China scare, or if you are fully comfortable paying 33 times for a franchise whose single live risk is Chinese demand holding and makeup staying off. What would turn a wait into a buy? China holding near its current pace, the 6%+ growth rate carrying into the second half, and the margin record holding. What would break it? China decelerating meaningfully, or makeup dragging the rest of the business down — at 33 times, there is little room for error.